|
|
||||||||
The Journal of Immunology, Vol 130, Issue 3 1132-1138, Copyright © 1983 by American Association of Immunologists
ARTICLES |
KC Anderson, EK Park, MP Bates, RC Leonard, R Hardy, SF Schlossman and LM Nadler
Two monoclonal antibodies that define distinct plasma cell-associated antigens, termed PCA-1 and PCA-2, were developed against human plasma cell leukemia cells. These antigens are strongly expressed on human myelomas, plasma cell leukemia, and plasmacytoma tumor cells, but are not detected on other lymphoid malignancies of B, T, null, or myeloid origin. PCA-1 and PCA-2 are not expressed on either normal T or B lymphocytes, but are weakly expressed on granulocytes and monocytes. When pokeweed mitogen is used to induce human B lymphocyte differentiation, PCA-1 is expressed when other B cell determinants are lost and plasmacytoid morphology, intracytoplasmic immunoglobulins, and surface T10 staining characteristic of plasma cells appear. In contrast, PCA-2 cannot be induced and may therefore appear later in the B cell differentiation scheme. These antigens may be of utility for the study and regulation of normal and abnormal plasma cell growth, traffic, and tissue distribution and may aid in understanding heterogeneity within plasma cell dyscrasias.
This article has been cited by other articles:
![]() |
S. Ozaki, M. Kosaka, Y. Wakahara, Y. Ozaki, M. Tsuchiya, Y. Koishihara, T. Goto, and T. Matsumoto Humanized Anti-HM1.24 Antibody Mediates Myeloma Cell Cytotoxicity That Is Enhanced by Cytokine Stimulation of Effector Cells Blood, June 1, 1999; 93(11): 3922 - 3930. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ozaki, M. Kosaka, S. Wakatsuki, M. Abe, Y. Koishihara, and T. Matsumoto Immunotherapy of Multiple Myeloma With a Monoclonal Antibody Directed Against a Plasma Cell-Specific Antigen, HM1.24 Blood, October 15, 1997; 90(8): 3179 - 3186. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Seremetis, G Inghirami, D Ferrero, E. Newcomb, D. Knowles, G. Dotto, and R Dalla-Favera Transformation and plasmacytoid differentiation of EBV-infected human B lymphoblasts by ras oncogenes Science, February 3, 1989; 243(4891): 660 - 663. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |